It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BAYZF’s FA Score shows that 0 FA rating(s) are green whileGIFLF’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BAYZF’s TA Score shows that 6 TA indicator(s) are bullish while GIFLF’s TA Score has 3 bullish TA indicator(s).
BAYZF (@Pharmaceuticals: Major) experienced а -4.78% price change this week, while GIFLF (@Pharmaceuticals: Major) price change was +4.37% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.80%. For the same industry, the average monthly price growth was -2.44%, and the average quarterly price growth was -1.35%.
The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
BAYZF | GIFLF | BAYZF / GIFLF | |
Capitalization | 57.5B | 8.79B | 655% |
EBITDA | 12.1B | 726M | 1,667% |
Gain YTD | -45.518 | -9.048 | 503% |
P/E Ratio | 17.12 | 62.50 | 27% |
Revenue | 50.5B | 6.46B | 782% |
Total Cash | 7.98B | 557M | 1,432% |
Total Debt | 41.3B | 10.9B | 379% |
BAYZF | GIFLF | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 4 | 33 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 34 Fair valued | 18 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 89 | 86 | |
PRICE GROWTH RATING 1..100 | 85 | 77 | |
P/E GROWTH RATING 1..100 | 90 | 96 | |
SEASONALITY SCORE 1..100 | 95 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GIFLF's Valuation (18) in the null industry is in the same range as BAYZF (34). This means that GIFLF’s stock grew similarly to BAYZF’s over the last 12 months.
GIFLF's Profit vs Risk Rating (100) in the null industry is in the same range as BAYZF (100). This means that GIFLF’s stock grew similarly to BAYZF’s over the last 12 months.
GIFLF's SMR Rating (86) in the null industry is in the same range as BAYZF (89). This means that GIFLF’s stock grew similarly to BAYZF’s over the last 12 months.
GIFLF's Price Growth Rating (77) in the null industry is in the same range as BAYZF (85). This means that GIFLF’s stock grew similarly to BAYZF’s over the last 12 months.
BAYZF's P/E Growth Rating (90) in the null industry is in the same range as GIFLF (96). This means that BAYZF’s stock grew similarly to GIFLF’s over the last 12 months.
BAYZF | GIFLF | |
---|---|---|
RSI ODDS (%) | 2 days ago60% | 2 days ago42% |
Stochastic ODDS (%) | 2 days ago43% | 2 days ago49% |
Momentum ODDS (%) | 2 days ago60% | 2 days ago54% |
MACD ODDS (%) | 2 days ago55% | N/A |
TrendWeek ODDS (%) | 2 days ago69% | 2 days ago42% |
TrendMonth ODDS (%) | 2 days ago67% | 2 days ago54% |
Advances ODDS (%) | 10 days ago61% | N/A |
Declines ODDS (%) | 2 days ago65% | N/A |
BollingerBands ODDS (%) | 6 days ago51% | 2 days ago52% |
Aroon ODDS (%) | 2 days ago66% | 2 days ago54% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
UTRE | 49.01 | N/A | N/A |
US Treasury 3 Year Note ETF | |||
PMAR | 40.31 | -0.01 | -0.02% |
Innovator U.S. Equity Power BffrETF™-Mar | |||
DEEF | 28.98 | -0.08 | -0.28% |
Xtrackers FTSE Develop ex US Mulfact ETF | |||
HYZD | 22.44 | -0.08 | -0.36% |
WisdomTree Interest Rt Hdg Hi Yld Bd ETF | |||
IYF | 112.49 | -1.27 | -1.12% |
iShares US Financials ETF |
A.I.dvisor indicates that over the last year, BAYZF has been closely correlated with BAYRY. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAYZF jumps, then BAYRY could also see price increases.
Ticker / NAME | Correlation To BAYZF | 1D Price Change % | ||
---|---|---|---|---|
BAYZF | 100% | -0.51% | ||
BAYRY - BAYZF | 88% Closely correlated | -1.18% | ||
AZN - BAYZF | 20% Poorly correlated | +1.43% | ||
GIFOF - BAYZF | 12% Poorly correlated | N/A | ||
CSPCY - BAYZF | 12% Poorly correlated | +0.56% | ||
CHGCY - BAYZF | 11% Poorly correlated | +3.71% | ||
More |
A.I.dvisor tells us that GIFLF and GIFOF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GIFLF and GIFOF's prices will move in lockstep.
Ticker / NAME | Correlation To GIFLF | 1D Price Change % | ||
---|---|---|---|---|
GIFLF | 100% | N/A | ||
GIFOF - GIFLF | 32% Poorly correlated | N/A | ||
GIKLY - GIFLF | 27% Poorly correlated | +2.19% | ||
GRFS - GIFLF | 22% Poorly correlated | +5.64% | ||
AMRN - GIFLF | 21% Poorly correlated | -0.80% | ||
BAYZF - GIFLF | 6% Poorly correlated | -0.51% | ||
More |